Alcon
Novartis eyecare unit Alcon to set up new HQ in Geneva, Switzerland
September 11, 2018Manufacturing and Production Alcon, Novartis, eye care, pharma
Alcon, the eyecare unit of Novartis, is set to move to a new home next year, after its parent company …
Novartis spins off Alcon as CEO focuses drug search
June 29, 2018Medical Communications, Sales and Marketing Alcon, Novartis, eye care, pharma
Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.Novartis has …
Novartis misses Q3 forecast with $390m settlement payment, strong dollar
October 27, 2015Manufacturing and Production, Sales and Marketing Alcon, Novartis, Sandoz
Novartis reported lower-than anticipated third quarter earnings on Tuesday, hit by the $390 million settlement it has agreed to pay …
Sandoz and pharma division boost Novartis sales
July 21, 2015Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales
Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …
Novartis forms alliance with Google on ‘smart lens’
July 15, 2014Medical Communications, Sales and Marketing Alcon, Novartis, diabetes, e-health, google, smart lens, wearable
Novartis eye care division Alcon has struck a deal with Google to develop a ‘smart’ contact lens designed to help …
Novartis launches China investigation
September 18, 2013Medical Communications, Sales and Marketing Alcon, China, Novartis, corrpution
ThromboGenics/Novartis’ Jetrea gains NICE ‘yes’
August 30, 2013Alcon, Jetrea, NICE, Novartis, ThromboGenics
Novartis becomes global eye health leader as Alcon deal finalised
December 15, 2010Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology
Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …
Two $1 billion dollar acquisition deals go through
August 11, 2010Sales and Marketing Alcon, M&A, MA, Novartis, Ratiopharm, Teva
Two major acquisition deals mounted by Teva and Novartis are in their final stages as they move to complete potentially …
Novartis shines in first quarter
April 21, 2010Sales and Marketing 2010 financials, Alcon, Novartis
Novartis has had a very strong first quarter, its first under new chief executive Joe Jimenez, delivering a 25% increase …
Alcon directors protest Novartis takeover bid
January 6, 2010Research and Development, Sales and Marketing Alcon, Novartis
An independent committee of directors of Alcon has expressed its disappointment with the recent takeover bid from Novartis, saying the …
Novartis to acquire majority stake in Alcon
January 5, 2010Sales and Marketing Alcon, Novartis, eye care
Novartis plans to gain a majority hold of global eye care leader Alcon, significantly boosting its presence in the sector. …
